These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 2475243
1. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS. Cancer Res; 1989 Sep 15; 49(18):5185-90. PubMed ID: 2475243 [Abstract] [Full Text] [Related]
2. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy. Sauer T, Furu I, Beraki K, Jebsen PW, Ormerod E, Naess O. Cancer; 1998 Apr 25; 84(2):109-14. PubMed ID: 9570214 [Abstract] [Full Text] [Related]
3. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Viel A, Dall'Agnese L, Canzonieri V, Sopracordevole F, Capozzi E, Carbone A, Visentin MC, Boiocchi M. Cancer Res; 1995 Jun 15; 55(12):2645-50. PubMed ID: 7780979 [Abstract] [Full Text] [Related]
4. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients. Kapranos N, Karaiossifidi H, Kouri E, Vasilaros S. Anticancer Res; 1996 Jun 15; 16(6C):3987-90. PubMed ID: 9042324 [Abstract] [Full Text] [Related]
7. Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma. Terasaki-Fukuzawa Y, Kijima H, Suto A, Takeshita T, Iezumi K, Sato S, Yoshida H, Sato T, Shimbori M, Shiina Y. Int J Mol Med; 2002 Jan 15; 9(1):25-9. PubMed ID: 11744991 [Abstract] [Full Text] [Related]
8. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis. Mylonas I, Jeschke U, Shabani N, Kuhn C, Friese K, Gerber B. Oncol Rep; 2005 Jan 15; 13(1):81-8. PubMed ID: 15583806 [Abstract] [Full Text] [Related]
9. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables. Tannapfel A, Katalinic A, Köckerling F, Wittekind C. Am J Gastroenterol; 1997 Jul 15; 92(7):1182-6. PubMed ID: 9219795 [Abstract] [Full Text] [Related]
10. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Torres L, Ribeiro FR, Pandis N, Andersen JA, Heim S, Teixeira MR. Breast Cancer Res Treat; 2007 Apr 15; 102(2):143-55. PubMed ID: 16906480 [Abstract] [Full Text] [Related]
11. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma. de Candia P, Akram M, Benezra R, Brogi E. Hum Pathol; 2006 Aug 15; 37(8):1032-41. PubMed ID: 16867866 [Abstract] [Full Text] [Related]
12. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL. Breast Cancer Res Treat; 2007 Mar 15; 101(3):279-84. PubMed ID: 16835704 [Abstract] [Full Text] [Related]
13. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N. Cancer; 2002 Aug 15; 95(4):681-95. PubMed ID: 12209710 [Abstract] [Full Text] [Related]
14. [Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis]. Liu H, Mao H, Fu X. Zhonghua Zhong Liu Za Zhi; 2001 May 15; 23(3):224-7. PubMed ID: 11783092 [Abstract] [Full Text] [Related]
15. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors. Kouvaraki M, Gorgoulis VG, Rassidakis GZ, Liodis P, Markopoulos C, Gogas J, Kittas C. Cancer; 2002 May 01; 94(9):2454-65. PubMed ID: 12015771 [Abstract] [Full Text] [Related]
16. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Mariani-Costantini R, Escot C, Theillet C, Gentile A, Merlo G, Lidereau R, Callahan R. Cancer Res; 1988 Jan 01; 48(1):199-205. PubMed ID: 2825967 [Abstract] [Full Text] [Related]
17. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Cancer; 2003 Feb 01; 97(3):545-53. PubMed ID: 12548595 [Abstract] [Full Text] [Related]
18. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study. Wang C, Iakovlev VV, Wong V, Leung S, Warren K, Iakovleva G, Arneson NC, Pintilie M, Miller N, Youngson B, McCready DR, Done SJ. Genes Chromosomes Cancer; 2009 Dec 01; 48(12):1091-101. PubMed ID: 19760610 [Abstract] [Full Text] [Related]
19. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL. APMIS Suppl; 2003 Dec 01; (108):1-67. PubMed ID: 12874968 [Abstract] [Full Text] [Related]
20. Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Cancer Res; 1992 Nov 01; 52(21):6088-91. PubMed ID: 1356624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]